TRIPLE NEGATIVE BREAST CANCER Archives - DelveInsight

TRIPLE NEGATIVE BREAST CANCER

Triple Negative Breast Cancer Symptoms Causes Treatments
Key Facts To Know About Triple-Negative Breast Cancer In The Breast Cancer Awareness Month

October, worldwide, is designated as the Breast cancer awareness month. Pink ribbons. Pink colored tee-shirts. Pink banners. Going pink, wearing pink - the whole month is devoted to raising awaren...


latest pharma news
AZ, Daiichi inks an oncology deal; Moderna begins Phase III trial of its COVID-19 vaccine; No goo...

AZ, Daiichi put their trust into TROP2-based drugs, inks an oncology deal to together develop and commercialize DS-1062AstraZeneca has inked an oncology deal with Daiichi Sankyo to jointly de...


Human Epidermal Receptor 2 (HER2)/ HR2 positive negative Breast Cancer
New Therapeutic advances that have shifted the Breast cancer market scenario

HR-positive/HER2-negative breast cancer treatment landscape focuses on the complexity of the specific cancer type and the treatment differ according to the biomarker status. The trend suggests a g...


Pharma News
Zogenix acquires Modis Therapeutics; Amgen buys Otezla; CRISPR slows down the Breast cancer rate

Zogenix pays USD 250M upfront Modis clinical drugZogenix, a pharmaceutical company focused on advancing rare disease therapies, has collaborated with the Modis therapeutics. Modis Therapeutic...


Sanofi
Gordon and Betty Moore Foundation gives $85M; Omeicos raises; Sanofi signs deal; Lilly grabs

Gordon and Betty Moore Foundation gives USD 85 Million to stop delayed, erroneous diagnosticsThe Gordon and Betty Moore Foundation is putting up money for improving diagnostics. The Foundation fo...


INSIGHTS ON TRIPLE NEGATIVE BREAST CANCER

[caption id="attachment_3465" align="alignnone" width="800"] INSIGHTS ON TRIPLE NEGATIVE BREAST CANCER[/caption] To know more about TRIPLE NEGATIVE BREAST CANCER request for sample pag...


Merck sells biosimilars; AbbVie’s PARP; Pharma heads; Biogen looks to M&A

Merck sells biosimilars business to Fresenius Merck has divested its biosimilars business to fellow German drug maker Fresenius in a deal potentially worth 670 million euros. The drug maker said th...


Editor's Pick
An in-depth Assessment of the Top Drugs Launched by Leading Global Companies ...

Progress is driven by innovation. When it comes to developing novel medications and the...

Changing Dynamics of HIV-1 Treatment Market

The HIV-1 treatment market for naïve and experienced patients is evolving consistently....

Which Countries Top the Chart in Global Pharmaceutical Market?

The Pharmaceuticals segment of the Healthcare Industry has a significant market across ...

von Willebrand disease (VWD) – Misdiagnosis Still Prevalent!

Von Willebrand disease is a type of blood disorder that causes the blood to clot improp...

Analyzing the Key Companies and the Emerging Gene Therapy in the Dermatology ...

Advances in genetics research have sparked a surge in interest in gene therapy in derma...

ASCO Conference 2021
ASCO Conference 2021

The American Society of Clinical Oncology is a platform that provides a global connection to researchers, pharma companies, and healthcare professions standing against cancer, finding a cure for it.